What is Defiance Nasdaq Junior Biotechnology ETF (IBBJ)?

Defiance Nasdaq Junior Biotechnology ETF (IBBJ) is an ETF in the Financial Services sector, Asset Management industry. View full analysis on Stocks360.

What is the current price of IBBJ?

The current price of IBBJ is $29.87. Prices are updated in real time on Stocks360.

What is IBBJ's market capitalization?

IBBJ's market capitalization is $8,225,660.00, placing it in the small-cap tier.

Defiance Nasdaq Junior Biotechnology ETF (IBBJ)

ETF analysis · NASDAQ · Financial Services · Asset Management

$29.87

Market Cap

$8.23M

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.00

Day Range

$29.86 – $29.90

52-wk Range

$27.85 – $41.45

Avg Volume

N/A

Volume

2.20K

Defiance Nasdaq Junior Biotechnology ETF (IBBJ) is an exchange-traded fund in the Financial Services sector. Latest price: $29.87. Market cap $8.23M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Defiance Nasdaq Junior Biotechnology ETF

This investment vehicle's primary objective is to track the overall performance, measured by total return, of the NASDAQ Junior Biotechnology Index, before accounting for any associated fees or expenses. The index itself is a rule-based compilation of U.S.-listed small-capitalization ("junior") biotechnology companies, carefully selected from the broader spectrum of businesses found within the NASDAQ Biotechnology Index. The fund typically implements a "replication" investment strategy, which means it generally acquires positions in all the component securities of its benchmark index, aiming to maintain their proportional weightings. This fund is designated as non-diversified.